{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:14:42Z","timestamp":1791332082420,"version":"4.3.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tuberculosis (TB) is the leading killer of people living with HIV (PLHIV) and almost one-third of deaths in the world are attributed to it and many of these deaths occur in developing countries. Despite these evidences, after the implementation of universal test and treat (UTT) strategy, information regarding the incidence and predictors of tuberculosis among PLHIV is limited in Ethiopia. Therefore, this study aimed to assess the incidence and predictors of tuberculosis among patients enrolled in Anti-Retroviral Therapy (ART) after universal test and treat program at St. Peter hospital and Zewditu Memorial Hospital, Addis Ababa, Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Institutional-based retrospective cohort study was conducted from November 1 to 30, 2020. Simple random sampling was used to select a total of 539 adults records which was enrolled on ART. Data was collected and entered into EPI DATA 3.1 and analyzed using STATA version 14.1. Time-to-event distributions were estimated using Kaplan\u2013Meier estimates. Hazards across different categories were compared using log-rank tests. Predictors were identified using the Cox proportional hazards model. The hazard ratio (HR) and 95% confidence interval (CI) were computed. Variables having P-value &lt; 0.05 from the multivariable analysis were considered as a statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Among 539 records reviewed, 529 (98%) were included in the final analysis. The total follow-up period was 1529 Person-Year (PY). The incidence rate in this cohort was found to be 4.84 per 100-person year (95%CI,3.83\u20136.11). CD4 count&lt;200 (AHR: 3.14,95% CI:1.64\u20137.10), poor adherence (AHR:2.16, 95% CI:1.21\u20133.85), underweight (AHR:2.42, 95% CI: 1.30\u20134.51), not taking isoniazid prophylaxis therapy (AHR: 2.78,95% CI: 1.06\u20137.30), being bedridden 3.06; (AHR: 3.06, 95% CI: 1.50\u20136.24), and baseline WHO stage three or four (AHR:2.33, 95% CI:1.08\u20135.02) were independent predictors for the incidence of TB among HIV positive patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, the incidence of tuberculosis is relatively low as compared to studies done before the initiation of test and treat program in Ethiopia. low CD4count, poor level of adherence, low BMI, not taking IPT prophylaxis, bedridden functional status, and being on baseline WHO stage III or IV were found to increase the hazard of tuberculosis. Hence, close follow up, reminders, surveillance, and tracing mechanisms targeting this higher risk group would decrease Tuberculosis among PLHIV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0272358","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:38:16Z","timestamp":1659533896000},"page":"e0272358","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study"],"prefix":"10.1371","volume":"17","author":[{"given":"Amare","family":"Getu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haileab Fekadu","family":"Wolde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaregal","family":"Animut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-5015","authenticated-orcid":true,"given":"Anteneh Ayelign","family":"Kibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"pone.0272358.ref001","first-page":"1","volume-title":"Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis;Recommendations from the National Tuberculosis ControllersAssociation and CDC","author":"Fenton Kevin","year":"2005"},{"key":"pone.0272358.ref002","first-page":"3","article-title":"Incidence and predictors of tuberculosis among adult people living with HIV\/AIDS in Afar public health facilities, Northeast Ethiopia.","volume":"1","author":"A Ahmed","year":"2015","journal-title":"AIDS"},{"issue":"10","key":"pone.0272358.ref003","first-page":"e0203986","article-title":"The twin epidemics: prevalence of TB\/HIV co-infection and its associated factors in Ethiopia; a systematic review and meta-analysis.","volume":"13","author":"B Tesfaye","year":"2018"},{"key":"pone.0272358.ref004","unstructured":"World Health Organisation (2019) Global Tuberculosis Report 2019. Geneva, Switzerland."},{"key":"pone.0272358.ref005","first-page":"2013","article-title":"Determinants of tuberculosis infection among adult HIV positives attending clinical care in western Ethiopia: acase-control study.","author":"H Melkamu","year":"2013","journal-title":"AIDS Res Treat"},{"key":"pone.0272358.ref006","volume-title":"Am J Respir Crit Care Med.","author":"World Health Organization","year":"2014"},{"key":"pone.0272358.ref007","unstructured":"Centers for Diseases control and prevention (CDC): Global HIV &Tuberculosis Ethiopia Country Profile available at https:\/\/www.cdc.gov\/globalhivtb\/where-we-work\/ethiopia\/ethiopia.html. In.; last reviewed:August 29, 2019. Accessed 06 Aug 2019."},{"issue":"9323","key":"pone.0272358.ref008","first-page":"2059","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"M Badri","year":"2002"},{"issue":"3","key":"pone.0272358.ref009","first-page":"185","article-title":"Incidence of tuberculosis and immunological profile of TB\/HIV co-infected patients in Nigeria.","volume":"10","author":"BM Musa","year":"2015"},{"issue":"6","key":"pone.0272358.ref010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.trstmh.2012.03.002","article-title":"Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia","volume":"106","author":"A Kassa","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"pone.0272358.ref011","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa:a prospective cohort","volume":"23","author":"E Jonathan","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"pone.0272358.ref012","doi-asserted-by":"crossref","first-page":"e64488","DOI":"10.1371\/journal.pone.0064488","article-title":"Determinant Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study","volume":"8","author":"KT Kibret","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"pone.0272358.ref013","first-page":"131","article-title":"Risk factors of active tuberculosis in people living with HIV\/AIDS in southwest Ethiopia: a case control study","volume":"21","author":"M Taha","year":"2011","journal-title":"Ethiop J Health Sci"},{"key":"pone.0272358.ref014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4172\/2157-7420.1000156","article-title":"Assessing the Effect of Highly Active AntiRetroviral Treatment and Associated Factors on Incidence of Tuberculosis among Adult HIV Positive Individuals in Assela, Ethiopia","volume":"5","author":"A Abebe","year":"2014","journal-title":"J Health Med Informat"},{"key":"pone.0272358.ref015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40794-020-00113-3","article-title":"\"Universal test and treat\" program reduced TB incidence by 75% among a cohort of adults taking antiretroviral therapy (ART) in Gurage zone, South Ethiopia.","volume":"6","author":"T Girum","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"pone.0272358.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/s40794-020-00113-3","article-title":"\u201cUniversal test and treat\u201d program reduced TB incidence by 75% among a cohort of adults taking antiretroviral therapy (ART) in Gurage zone, South Ethiopia.","author":"T Girum","year":"2020"},{"issue":"02","key":"pone.0272358.ref017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4236\/aid.2016.62010","article-title":"Incidence and predictors of tuberculosis among HIV\/AIDS infected patients: a five-year retrospective follow-up study","volume":"6","author":"M Dalbo","year":"2016","journal-title":"Adv Infect Dis"},{"issue":"11","key":"pone.0272358.ref018","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","article-title":"Tuberculosis incidence rate and risk factorsamong HIV-infected adults with access to antiretroviral therapy in Tanzania.","volume":"29","author":"L Enju","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"2","key":"pone.0272358.ref019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-126-2-199701150-00005","article-title":"Incidence of tuberculosis in the United States among HIV-infected persons","volume":"126","author":"N Markowitz","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"pone.0272358.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4031-2","article-title":"The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.","volume":"19","author":"D Geremew","year":"2019","journal-title":"BMC infectious diseases"},{"issue":"11","key":"pone.0272358.ref021","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviraltherapy and isoniazid preventive therapy on tuberculosis incidence in HIVinfectedpatients in Rio de Janeiro, Brazil.","volume":"21","author":"JE Golub","year":"2007","journal-title":"AIDS (London, England)"},{"key":"pone.0272358.ref022","unstructured":"CDC. Ethiopia\u2014CDC Division of Global HIV & TB\u2014Country Profile. 2019."},{"key":"pone.0272358.ref023","article-title":"Antiretroviral therapy in the control of HIV associated tuberculosis in resource-limited settings.","author":"SD Lawn","year":"2009","journal-title":"Clinics in Chest Medicine"},{"issue":"4","key":"pone.0272358.ref024","doi-asserted-by":"crossref","first-page":"e93106","DOI":"10.1371\/journal.pone.0093106","article-title":"Incidence and predictors of first line antiretroviral regimen modification in western Kenya.","volume":"9","author":"S Inzaule","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"pone.0272358.ref025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0962-8479(92)90033-G","article-title":"HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention","volume":"73","author":"JP Narain","year":"1992","journal-title":"Tubercle and lung disease"},{"issue":"1","key":"pone.0272358.ref026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD 4+ T\u2010cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"AA Okoye","year":"2013","journal-title":"Immunological reviews"},{"issue":"1","key":"pone.0272358.ref027","first-page":"1","article-title":"Intensified tuberculosis case finding, implementation of isoniazid preventive therapy and associated factors among people living with human immunodeficiency virus at public health facilities of Harari region, eastern Ethiopia: a cross-sectional study","volume":"11","author":"A Geleto","year":"2017","journal-title":"Int J Health Sci"},{"issue":"12","key":"pone.0272358.ref028","article-title":"The Importance of Treatment Adherence in HIV.","volume":"19","author":"L. Kenneth","year":"2013","journal-title":"Supplements and Featured Publications"},{"issue":"3","key":"pone.0272358.ref029","doi-asserted-by":"crossref","first-page":"e0248490","DOI":"10.1371\/journal.pone.0248490","article-title":"Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.","volume":"16","author":"M Abdu","year":"2021","journal-title":"PloS one"},{"key":"pone.0272358.ref030","first-page":"1447","article-title":"Low BMI and falling BMI predict HIV-associated tuberculosis: a prospective study in Tanzania.","volume":"14","author":"I Maro","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0272358.ref031","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","article-title":"Tuberculosis incidence rate andrisk factors among HIV-infected adults with access to antiretroviral therapy","volume":"29","author":"E Liu","year":"2015","journal-title":"AIDS"},{"issue":"2","key":"pone.0272358.ref032","doi-asserted-by":"crossref","first-page":"e016961","DOI":"10.1136\/bmjopen-2017-016961","article-title":"Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study","volume":"8","author":"A Ahmed","year":"2018","journal-title":"BMJ open"},{"key":"pone.0272358.ref033","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2334-13-292","article-title":"Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia.","volume":"13","author":"A Alene","year":"2013","journal-title":"BMC Infectious Diseases"},{"key":"pone.0272358.ref034","first-page":"2422","article-title":"Determinants of Active Tuberculosis among HIV-Positive Adults Attending Clinical Care in Ambo general hospital and Gedo hospital,West Shoa Zone, Oromia, Ethiopia (unmatched case-controlstudy).","volume":"33","author":"MI Habtamu Oljira","year":"2015","journal-title":"J Med Physiol Biophys."},{"issue":"18","key":"pone.0272358.ref035","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a south African cohort","volume":"19","author":"SD Lawn","year":"2005","journal-title":"Aids"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:38:44Z","timestamp":1659533924000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272358"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0272358","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}